Quantitative fecal immunochemical test guided colonoscopy on the detection rate of colorectal lesions: a multicenter randomized controlled trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200057127

Enrollment

Unknown

Registered

2022-02-28

Start date

2022-02-14

Completion date

Unknown

Last updated

2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

Experimental group:Guided by FIT

Control group:None

Eligibility

Sex/Gender

All

Age

50 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 50-75 years who want to undergo colonoscopy screening for colorectal cancer; 2. Fecal immune occult blood test has been completed before colonoscopy.

Exclusion criteria

Exclusion criteria: 1. Unqualified bowel preparation; 2. Patients with hereditary colorectal cancer (such as familial adenomatous polyposis, Lynch syndrome, etc.); 3. Inflammatory bowel disease; 4. A history of colonoscopy within 5 years; 5. Unable to cooperate with severe mental or systemic diseases; 6. Patients during pregnancy and lactation; 7. Failure to sign informed consent.

Design outcomes

Primary

Measure	Time frame
advanced neoplasm detection rate;	—

Countries

China

Contacts

Public ContactLi Yanqing

liyanqing@sdu.edu.cn+86 531 88369277

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026